These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Variability in telavancin cross-reactivity among vancomycin immunoassays. McConeghy KW; Liao S; Clark D; Worboys P; Barriere SL; Rodvold KA Antimicrob Agents Chemother; 2014 Dec; 58(12):7093-7. PubMed ID: 25223996 [TBL] [Abstract][Full Text] [Related]
23. Potential problem with fluorescence polarization immunoassay cross-reactivity to vancomycin degradation product CDP-1: its detection in sera of renally impaired patients. Anne L; Hu M; Chan K; Colin L; Gottwald K Ther Drug Monit; 1989 Sep; 11(5):585-91. PubMed ID: 2683253 [TBL] [Abstract][Full Text] [Related]
24. Development and validation of a new ultra-performance liquid chromatographic method for vancomycin assay in serum and its application to therapeutic drug monitoring. Cao Y; Yu J; Chen Y; Zhang J; Wu X; Zhang Y; Li G Ther Drug Monit; 2014 Apr; 36(2):175-81. PubMed ID: 24216537 [TBL] [Abstract][Full Text] [Related]
25. Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy. Barth RH; DeVincenzo N Kidney Int; 1996 Sep; 50(3):929-36. PubMed ID: 8872968 [TBL] [Abstract][Full Text] [Related]
26. A Bayesian Model to Describe Factors Influencing Trough Levels of Vancomycin in Hemodialysis Patients. Sansot C; Kalbacher E; Lemoine S; Bourguignon L; Fauvel JP; Ducher M Nephron; 2015; 131(2):131-7. PubMed ID: 26376164 [TBL] [Abstract][Full Text] [Related]
27. Whole blood cyclosporin monitoring in liver and heart transplant patients: evaluation of the specificity of a fluorescence polarization immunoassay and an enzyme-multiplied immunoassay technique. Gulbis B; Van der Heijden J; van As H; Thiry P J Pharm Biomed Anal; 1997 Apr; 15(7):957-63. PubMed ID: 9160262 [TBL] [Abstract][Full Text] [Related]
28. Precision and accuracy of commercial assays for vancomycin therapeutic drug monitoring: evaluation based on external quality assessment scheme. Chen CY; Li MY; Ma LY; Zhai XY; Luo DH; Zhou Y; Liu ZM; Cui YM J Antimicrob Chemother; 2020 Aug; 75(8):2110-2119. PubMed ID: 32464644 [TBL] [Abstract][Full Text] [Related]
30. The effect of paraproteins and rheumatoid factor on four commercial immunoassays for vancomycin: implications for laboratorians and other health care professionals. LeGatt DF; Blakney GB; Higgins TN; Schnabl KL; Shalapay CE; Dias VC; Wesenberg JC Ther Drug Monit; 2012 Jun; 34(3):306-11. PubMed ID: 22569352 [TBL] [Abstract][Full Text] [Related]
31. Clinical estimation of vancomycin measurement method on hemodialysis patient. Tanaka M; Orii T; Gomi T; Kobayashi H; Kanke M; Hirono S Yakugaku Zasshi; 2002 Apr; 122(4):269-75. PubMed ID: 11968839 [TBL] [Abstract][Full Text] [Related]
32. Accuracy of measured vancomycin serum concentrations in patients with end-stage renal disease. Smith PF; Morse GD Ann Pharmacother; 1999 Dec; 33(12):1329-35. PubMed ID: 10630833 [TBL] [Abstract][Full Text] [Related]
33. Measurement of vancomycin in renally impaired patient samples using a new high-performance liquid chromatography method with vitamin B12 internal standard: comparison of high-performance liquid chromatography, emit, and fluorescence polarization immunoassay methods. Hu MW; Anne L; Forni T; Gottwald K Ther Drug Monit; 1990 Nov; 12(6):562-9. PubMed ID: 2275003 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of commercial assays for vancomycin and aminoglycosides in serum: a comparison of accuracy and precision based on external quality assessment. Wilson JF; Davis AC; Tobin CM J Antimicrob Chemother; 2003 Jul; 52(1):78-82. PubMed ID: 12805260 [TBL] [Abstract][Full Text] [Related]
35. Accuracy of vancomycin serum concentrations in patients with renal failure. Perino LM; Mueller BA Ann Pharmacother; 1993; 27(7-8):892-3. PubMed ID: 8364273 [No Abstract] [Full Text] [Related]
36. Comparison of bioassay, high-performance liquid chromatography, and fluorescence polarization immunoassay for quantitative determination of vancomycin in serum. Ristuccia PA; Ristuccia AM; Bidanset JH; Cunha BA Ther Drug Monit; 1984; 6(2):238-42. PubMed ID: 6377600 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of Innofluor fluorescence polarization immunoassay kits for the determination of serum concentrations of gentamicin, tobramycin, amikacin and vancomycin.lesassays@ukneqasaa.win-uk.net. White LO; Holt HA; Reeves DS; MacGowan AP J Antimicrob Chemother; 1997 Mar; 39(3):355-61. PubMed ID: 9096185 [TBL] [Abstract][Full Text] [Related]
38. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis. Schaedeli F; Uehlinger DE Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of an automated fluorescence polarization immunoassay for vancomycin. Filburn BH; Shull VH; Tempera YM; Dick JD Antimicrob Agents Chemother; 1983 Aug; 24(2):216-20. PubMed ID: 6357070 [TBL] [Abstract][Full Text] [Related]
40. Comparison of fluorescence polarization immunoassay and bioassay of vancomycin. Pohlod DJ; Saravolatz LD; Somerville MM J Clin Microbiol; 1984 Aug; 20(2):159-61. PubMed ID: 6436291 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]